Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Receivables - Other (2013 - 2024)

Updated

Altamira Therapeutics' Receivables - Other was $351,331 in Q4 2024, up 316.5% from $84,352 a year earlier.

Analysis

Altamira Therapeutics (CYTOF) Receivables - Other (2013 - 2024) Analysis & Trends

From Q4 2021 onward, Altamira Therapeutics has reported Receivables - Other for 4 quarters.

  • Receivables - Other shows a three-year compound annual growth rate of -21.6% (FY2021 to FY2024).
  • In earlier years, Receivables - Other was $88,916 in FY2023 (-88.7%), $784,731 in FY2022 (+7.8%) and $728,070 in FY2021.
  • The Q4 2024 figure marks the highest quarterly Receivables - Other since Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 351,331.00
Dec 31, 2023 88,720.12
Dec 31, 2022 819,187.28
Dec 31, 2021 734,748.86
Jun 30, 2020 21,030.44
Dec 31, 2019 20,648.75
Jun 30, 2019 16,383.56
Dec 31, 2018 16,267.79
Jun 30, 2018 76,895.31
Mar 31, 2018 80,240.59
Dec 31, 2017 78,379.48
Sep 30, 2017 89,672.16
Dec 31, 2016 112,848.29
Dec 31, 2015 54,606.28
Dec 31, 2014 45,798.86
Dec 31, 2013 591,505.87
API Access

Altamira Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CYTOF&period=max&api_key=YOUR_API_KEY